Federal contract award
75D30123F17603
ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | CDC OFFICE OF ACQUISITION SERVICES |
| NAICS | 541611 — Administrative Management and General Management Consulting Services |
| PSC | B529 — Scientific Data Studies |
| Parent award / vehicle | GS00F123DA |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $2.8M |
| Current contract value | $2.8M |
| Potential contract value / ceiling | $6.1M |
| Start date | Sep 19, 2023 |
| Current end date | Oct 26, 2027 |
| Potential end date | Oct 26, 2027 |
| Latest award activity | Jul 22, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 10 of 10 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jul 22, 2026 | P00008 | $0 | DESCOPE TASK 1 FROM 12 TO 9 MONTHS, REDUCE COSTS ASSOCIATED W/ DESCOPE AND EXERCISE OY2 TASK 1 |
| Jun 9, 2026 | P00009 | $0 | EO 14398 |
| Feb 12, 2026 | P00007 | $473.2K | DESCOPE TASK 1 FROM 12 TO 9 MONTHS, REDUCE COSTS ASSOCIATED W/ DESCOPE AND EXERCISE OY2 TASK 1 |
| Jul 17, 2025 | P00006 | $458.0K | DESCOPE TASK 1 FROM 12 TO 9 MONTHS, REDUCE COSTS ASSOCIATED W/ DESCOPE AND EXERCISE OY2 TASK 1 |
| Feb 26, 2025 | P00005 | $0 | EOI::EO 14168 DEFENDING WOMEN FROM GENDER IDEOLOGY EXTREMISM AND RESTORING BIOLOGICAL TRUTH::EOI SUPPLEMENTAL AGREEMENT |
| Oct 22, 2024 | P00004 | $0 | ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE |
| Aug 16, 2024 | P00003 | $823.8K | ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE |
| Jul 23, 2024 | P00002 | $288.1K | ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE |
| Nov 27, 2023 | P00001 | $0 | ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE |
| Sep 19, 2023 | 0 | $798.9K | ONGOING ASSESSMENT OF COVID-19 AND INFLUENZA VACCINATION RECEIPT AND RELATED KNOWLEDGE |
Estimated positioning window
Oct 26, 2026 – Apr 26, 2027
75/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 75/100. Available recorded signals: 70 points.
- Contract end 2027-10-26 (366 days from calculation)
- +25 points
- 5 historical awards in this buyer and category group
- +15 points
- 10 recorded award transactions
- +10 points
- Latest award action: 2026-07-22
- +5 points
- Parent award identifier recorded
- +5 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.